Marinus Pharmaceuticals IPO Research Information

Marinus Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Marinus Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Marinus Pharmaceuticals	MRNS - NASDAQ	$12.00-$14.00	$8.00	$8.00	5.62 million	7/31/2014
Underwriter(s): Stifel, JMP Securities
Co-Manager(s): Oppenheimer & Co., Janney Montgomery Scott
Industry: Health Care
Filing(s): Filed 2014-05-13 Terms Added 2014-07-18

Marinus Pharmaceuticals Quote & Chart - Click for current quote - MRNS

About Marinus Pharmaceuticals (adapted from Marinus Pharmaceuticals prospectus):
They are a clinical stage biopharmaceutical company focused on developing and commercializing innovative neuropsychiatric therapeutics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "MRNS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.